A

Alexion

Global biopharmaceuticals focusing on rare diseases

Associate Director - Market Access

Corporate StrategyConfirmed live in the last 24 hours
Full-timeMunich, GermanyNo salary listedIn-person

About the Job

Requirements

  • An advanced degree in Life Sciences, Medicine, Epidemiology, or a related discipline.
  • At least 5 years of significant experience in pharmaceutical or biotechnology Market Access, Pricing and Reimbursement, or specialized Market Access consultancy.
  • Deep knowledge of the German healthcare system, reimbursement environment, AMNOG legislation, and reimbursement processes.
  • Hands-on experience and demonstrated success in AMNOG dossier development, benefit assessment strategy, and related procedures, including oral hearings, reimbursement discussions, launch readiness, and price negotiations.
  • A strong track record in operational pricing processes, launch pricing preparation, governance, and lifecycle price management.
  • Ability to work within matrix organizations, serve on Brand and Launch Teams, and collaborate with global organizations.
  • Project leadership skills and ability to influence cross-functional teams and stakeholders without direct authority to deliver measurable business outcomes.
  • Practical application and understanding of Artificial Intelligence, advanced analytics, and digital solutions to support business objectives.
  • Strategic thinking, analytical capabilities, and critical thinking skills.
  • Fluency in German and English.
  • Integrity, accountability, business acumen, and ability to manage multiple complex projects simultaneously.

Responsibilities

  • Develop and execute national market access and pricing strategies for assigned assets.
  • Represent Market Access on cross-functional brand and launch teams and drive launch preparation, AMNOG processes, reimbursement, pricing, stakeholder engagement, and operational pricing for assigned assets.
  • Lead creation of AMNOG dossiers, payer value propositions, and access strategies for pipeline and marketed products.
  • Prepare for G-BA consultations, written statements, and oral hearings, and support reimbursement price negotiations and operational pricing.
  • Collaborate with Medical Affairs, Commercial, Regulatory, Government Affairs, Legal, HEOR, Global Market Access, and other teams to support launch execution and reimbursement outcomes.
  • Develop analyses, monitor the competitor landscape, and create tools and solutions to improve planning, stakeholder engagement, and operational effectiveness.
  • Drive local market access strategies and tactical plans for assigned therapeutic areas, providing strategic input throughout product development, commercialization, and lifecycle management.
  • Lead end-to-end AMNOG dossier development, including strategy, data analysis, value argumentation, comparator strategy, and clinical evidence assessment.
  • Support AMNOG procedures, including G-BA consultations, statements, hearings, and price negotiations, and create payer value propositions for the German market.
  • Generate access insights and payer perspectives for product strategy, forecasting, launch readiness, and long-term planning; analyze healthcare policy and pricing developments and provide business recommendations.
  • Lead cross-functional access and pricing workstreams and develop, optimize, and maintain business cases, access and funding models, pricing tools, reimbursement trackers, and digital decision-support resources.
  • Build relationships with payer experts, healthcare decision-makers, and external advisors; organize advisory boards and collaborate with Field teams on account work.
  • Manage local pricing activities, including database maintenance, governance, launch assumptions, and lifecycle price changes; liaise with Global and Finance teams and provide input for business reviews.
  • Use Artificial Intelligence, advanced analytics, and digital technologies to improve evidence synthesis, dossier development, competitive intelligence, and operational efficiency.
  • Collaborate with global colleagues to integrate local market access requirements into development programs and evidence-generation activities.

Desired Qualifications

  • Experience in rare disease or specialty care.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs